<?xml version='1.0' encoding='UTF-8'?>
<rss xmlns:arxiv="http://arxiv.org/schemas/atom" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" version="2.0">
  <channel>
    <title>q-bio.PE updates on arXiv.org</title>
    <link>http://rss.arxiv.org/rss/q-bio.PE</link>
    <description>q-bio.PE updates on the arXiv.org e-print archive.</description>
    <atom:link href="http://rss.arxiv.org/rss/q-bio.PE" rel="self" type="application/rss+xml"/>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <language>en-us</language>
    <lastBuildDate>Thu, 22 May 2025 04:00:09 +0000</lastBuildDate>
    <managingEditor>rss-help@arxiv.org</managingEditor>
    <pubDate>Thu, 22 May 2025 00:00:00 -0400</pubDate>
    <skipDays>
      <day>Sunday</day>
      <day>Saturday</day>
    </skipDays>
    <item>
      <title>In Silico Trials for Sex-Specific patient Inclusion Criteria in Cardiac Resynchronization Therapy: Advancing Precision in Heart Failure Treatment</title>
      <link>https://arxiv.org/abs/2505.15708</link>
      <description>arXiv:2505.15708v1 Announce Type: cross 
Abstract: Cardiac resynchronization therapy (CRT) guidelines are based on clinical trials with limited female representation and inconsistent left bundle branch block (LBBB) definitions. Conventional QRS duration (QRSd) criteria show variable diagnostic accuracy between sexes, partly due to differences in heart size and remodeling. We evaluated the influence of sex, heart size, LBBB, and conduction delay on QRSd and assessed the diagnostic performance of conventional and indexed QRSd criteria using a population-based modelling approach. Simulated QRSd were derived from electrophysiological simulations conducted in 2627 UK Biobank healthy participants and 359 patients with ischemic heart disease, by modelling LBBB and normal activation combined with/without conduction delay. QRSd criteria under-selected LBBB females and over-selected non-LBBB patients. Indexing by LVEDV and LV mass reduced sex disparities but increased the over-selection in non-LBBB patients. Height-indexed QRSd effectively resolved sex differences and maintained low non-LBBB selection rates, demonstrating superior performance and potential for more equitable CRT selection.</description>
      <guid isPermaLink="false">oai:arXiv.org:2505.15708v1</guid>
      <category>physics.med-ph</category>
      <category>q-bio.PE</category>
      <pubDate>Thu, 22 May 2025 00:00:00 -0400</pubDate>
      <arxiv:announce_type>cross</arxiv:announce_type>
      <dc:rights>http://creativecommons.org/licenses/by/4.0/</dc:rights>
      <dc:creator>Shuang Qian, Devran Ugurlu, Elliot Fairweather, Richard E Jones, Hassan Zaidi, Sanjay Prasad, Brian P Halliday, Daniel J Hammersley, Gernot Plank, Edward Vigmond, Christopher A Rinaldi, Alistair Young, Pablo Lamata, Martin Bishop, Steven Niederer</dc:creator>
    </item>
    <item>
      <title>Petri nets in epidemiology</title>
      <link>https://arxiv.org/abs/2206.03269</link>
      <description>arXiv:2206.03269v3 Announce Type: replace 
Abstract: This work provides a geometric version of the next-generation matrix method for obtaining the basic reproduction number of an epidemiological model. We exhibit a certain correspondence between any system of ODEs and Petri nets. We observe that any epidemiological model has the basic structures found in the SIR model of Kermack-McKendrick. This means that the basic reproduction number depends only on three substructures inside the Petri net, which are also given by three Petri nets inside, representing the susceptible population, the infection process, and the infected population. The five assumptions of the next-generation matrix method given by van den Driessche-Watmough can be described geometrically using Petri nets. Thus, the next-generation matrix results in a matrix of flows between the infection compartments with a dominant eigenvalue given by the basic reproduction number.</description>
      <guid isPermaLink="false">oai:arXiv.org:2206.03269v3</guid>
      <category>q-bio.PE</category>
      <pubDate>Thu, 22 May 2025 00:00:00 -0400</pubDate>
      <arxiv:announce_type>replace</arxiv:announce_type>
      <dc:rights>http://arxiv.org/licenses/nonexclusive-distrib/1.0/</dc:rights>
      <dc:creator>Carlos Segovia</dc:creator>
    </item>
  </channel>
</rss>
